endovascular_avf

31

Upload: marinamiteva

Post on 06-Aug-2015

13 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Endovascular_AVF
Page 2: Endovascular_AVF

Introduction

• 300 – 400: 1 000 000 worldwide

• CRD in Bulgaria is nearly twicehigher than the average for the EU -almost 26%

Morbidity of Chronic RenalDisease:

Page 3: Endovascular_AVF

IntroductionPermanent vascular access

(PVA) includes all methods ofrealizing an arteriovenous

anastomosis (fistula) - AVF.

Page 4: Endovascular_AVF

Complications of the AVF:

• hemodynamically significant stenosis;• infection of the PVA;

• thrombosis ;

• pseudoaneurism;• rupture of the PVA.

Introduction

Page 5: Endovascular_AVF

Endovascular treatment ofPVA is a safer alternative of

the operative one.

Introduction

Page 6: Endovascular_AVF

IntroductionHemodynamically significant stenosis is

present when the normal vasculardiameter is reduced by 50% or more.

• increased static or dynamic pressure;• decreased blood capacity;• groundless dialysis cleansing;• swallowing of the extremity.

Page 7: Endovascular_AVF

Introduction

Stenosis found before it thromboses iseasier to be treated than post-

thrombotic one and shows 79%reliability. Reliability of post-

thrombotic treatment of the stenosisdecreases to 40%.

Page 8: Endovascular_AVF

PTA

The preferred method of treatment foreither arterial or venous stenosis of PVA is

Percutaneous Transluminal Angioplasty(PTA).

Page 9: Endovascular_AVF

PTAIndicator of dysfunction:

• greater than 25% decrease in flow over3-4 month period;

• elevated urea recirculation;• arm swelling;• poor thrill/pulsatile;• poor maturation of fistula.

Page 10: Endovascular_AVF

PTA

Balloons:

• High-pressurenon-compliant;

• “Coronary”type balloons;

• Cuttingballoons;

• Oversizedballoons.

Page 11: Endovascular_AVF

PTA + Stenting

Stenting combined with PTA isindicated when elastic stenosis is

present or relapse of stenosis for aperiod of 3 months.

Page 12: Endovascular_AVF

Stents:

• Self-expandingstents;

• Bare stents;• Covered stents;• Balloon-

expandablestents.

PTA + Stenting

Page 13: Endovascular_AVF

PTA

The typical endpoint is restoration ofnormal trill to the fistula. A successful

angioplasty will have complete effacementof the balloon waist and result in 0 - 30%

residual narrowing.

Page 14: Endovascular_AVF

PTAContraindications:

• Infected AVF;• Uncorrectable severe coagulopathy;• Severe allergy to iodinated contrast

agents;• Percutaneous intervention on a

newly placed graft.

Page 15: Endovascular_AVF

Treatment of clotted AVF is eitherendovascular thrombectomy (ET)

or thrombolysis.

Page 16: Endovascular_AVF

Sweeping thrombus from the occludedgraft into the central venous circulation

Pulmonary circulation embolization

ET Balloon-Sweep

Page 17: Endovascular_AVF

Contraindications:

• Patients with cardiopulmonarycompromise;

• Known right-to-left intracardiac shunt,especially with pulmonary hypertension.

ET Balloon-Sweep

Page 18: Endovascular_AVF

Endovascular thrombectomy is mostcommonly performed by using

thromboaspiration, combined withangioplasty. It is most useful with

fresh thrombus .

ET Thromboaspiration

Page 19: Endovascular_AVF

Mechanical thrombectomydevices are designed to removethrombus quickly, effectively,and safely from hemodialysis

grafts.

ET Devices

Page 20: Endovascular_AVF

Recirculation-type devices create ahydrodynamic vortex, which homogenizes

the thrombus converting it into slurry.

ET Devices

Page 21: Endovascular_AVF

Recirculation-type devices include:

• Helix• Xpeedior• Oasis catheter• Hydrolyser catheter• Thrombex PMT

ET Devices

Page 22: Endovascular_AVF

The non-recirculation-type devices use arapidly spinning wire basket or plastic brush

to mechanically fragment the thrombus.

ET Devices

Page 23: Endovascular_AVF

Non-recirculation-type devicesinclude:

• Trerotola-PTD• Thrombolytic brush catheter(Cragg/Castaneda)

ET Devices

Page 24: Endovascular_AVF

Thrombolysis is taken in considerationmainly in combination with other methods

of endovascular treatment of PVA andespecially during the first couple of hours

after thrombosis.

Thrombolysis

Page 25: Endovascular_AVF

Results

Immediate patency 3-month patency 6-month patency

Angioplasty 0 – 30% residualnarrowing

- 50%

Thrombectomy >85% 40% 20 - 40%

Short-term results:

Page 26: Endovascular_AVF

Results

Long-term patency of vascular access isdependent on the identification and

successful treatment of all significantstenoses.

Long-term Results:

Page 27: Endovascular_AVF

Long-term results should be consideredonly when angioplasty with/without

stenting is performed.

Results

Page 28: Endovascular_AVF

Endovascular therapy requires qualifiedmedical team and adequately equippedoperating room. The medical supplies

needed for these procedures are expensiveand in this sense endovascular treatment

of AVF in Bulgaria is financiallycompromised.

Conclusion

Page 29: Endovascular_AVF

References1. Handbook of Angioplasty and Stenting

Procedures, Techniques in IR series, LeeWatkinson;

2. Съдов достъп. Перитонеална диализа, проф.Д-р Здравко Краев;

3. Dialysis Access: A Multidisciplinary Approach ,Richard James Gray,Jeffrey J. Sands;Endovascular Interventions: A Case-BasedApproach, Robert S. Dieter,Raymond A. Dieter,Jr. ,Raymond A. Dieter, III,AravindaNanjundappa

4. Vascular Surgery, SIXTH EDITION, Robert B.Rutherford MD, FACS, FRCS (Glasg.)

5. Haimovici's Vascular Surgery, 6th Edition

Page 30: Endovascular_AVF

Thank you for yourattention!

Page 31: Endovascular_AVF

???Questions ???